Akari Therapeutics plc ADR (0.01 USD) (AKTX) Stock Price, Quote & AI Analysis
Live AKTX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Akari Therapeutics plc ADR (0.01 USD).
TradeVae provides AI-driven analysis and real-time market intelligence for Akari Therapeutics plc ADR (0.01 USD) (AKTX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Akari Therapeutics plc ADR (0.01 USD)'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Akari Therapeutics plc ADR (0.01 USD) Overview
Company information
Company Overview
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Akari Therapeutics plc ADR (0.01 USD) Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...